You just read:

FDA Approves BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Lower Limb Spasticity, Excluding Spasticity Caused by Cerebral Palsy

News provided by

Allergan plc

Oct 24, 2019, 07:30 ET